• Circulating Tumor Cells (CTC), Prostate Cancer
  • Uric Acid, Serum
  • Activated Clotting Time (ACT)
  • Vanillylmandelic Acid (VMA), 24 Hour, Urine
  • Solute Carrier Family 22 (SLC22A5) Gene Mutation Analysis
  • PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio
  • Gastrointestinal Viral Pathogen Panel, Molecular
  • Chromosome Analysis, Chorionic Villus Sampling
  • Diphtheria Toxoid Antibody, IgG
  • Folic Acid (Folate), RBC
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Circulating Tumor Cells (CTC), Prostate Cancer
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Circulating Tumor Cells (CTC), Prostate Cancer
Medical Test

Specimen Collection
Access to Circulating Tumor Cells (CTC), Prostate Cancer is restricted.
Loading...